DNA Biomed Solns (DNA) — Strategic Asset Allocation Index
DNA Biomed Solns (DNA) has a Strategic Asset Allocation Index of 133.7% as of June 2019. Strategic assets (PP&E of ILA- plus long-term investments of ILA51.99 Million) total ILA51.99 Million, measured against net assets of ILA38.87 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
DNA Biomed Solns Strategic Asset Allocation Index (2005–2018)
This chart shows how DNA Biomed Solns's Strategic Asset Allocation Index has evolved across 6 annual periods from 2005 to 2018. As of June 2019, the index stands at 133.7%, representing strategic assets of ILA51.99 Million against net assets of ILA38.87 Million ILA. Explore cash efficiency ratio of DNA Biomed Solns to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for DNA Biomed Solns (2005–2018)
The table below presents the year-by-year Strategic Asset Allocation Index for DNA Biomed Solns from 2005 to 2018, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see DNA market cap overview.
| Year | SAAI | Strategic Assets (ILA) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2018 | 123.6% | ILA80.20 Million | ILA- | ILA80.20 Million | ILA64.90 Million | ▲ +12.9 pp |
| 2017 | 110.7% | ILA76.49 Million | ILA- | ILA76.49 Million | ILA69.11 Million | ▲ +60.8 pp |
| 2013 | 49.9% | ILA5.74 Million | ILA99.00K | ILA5.64 Million | ILA11.49 Million | ▲ +49.8 pp |
| 2012 | 0.2% | ILA18.00K | ILA18.00K | ILA- | ILA11.53 Million | ▼ 0.0 pp |
| 2011 | 0.2% | ILA18.00K | ILA18.00K | ILA- | ILA10.45 Million | ▼ -28.4 pp |
| 2005 | 28.6% | ILA931.00K | ILA931.00K | ILA- | ILA3.26 Million | — |